T1D patients depend on exogenous insulin throughout life, and their wellbeing is typically compromised by both hyperglycaemia (a consequence of poor control of the disease) and hypoglycaemia, due to improper insulin treatment [1]. The gene discussed is INS; the disease is Hypoglycemia.